The company raised $36 million in an oversubscribed series C financing with the help of Israel-U.S. investors, according to a March 30 news release. The series C financing comes eight months after Augmedics closed a $21 million series B financing. The total funding is now $63 million.
Augmedics creates augmented reality surgical imaging guidance. Its Xvision system has been used by spine surgeons across the U.S.
More articles on devices:
Spinal fusion ‘picking up steam’ at ASCs: 2 leaders discuss practice growth
Alphatec, NuVasive & SeaSpine: Key spine acquisitions in 2021
Why endoscopic spine surgery in the US lags behind Europe, Asia
